179 related articles for article (PubMed ID: 20349177)
1. Analytic model comparing the cost utility of TVT versus duloxetine in women with urinary stress incontinence.
Jacklin P; Duckett J; Renganathan A
Int Urogynecol J; 2010 Aug; 21(8):977-84. PubMed ID: 20349177
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.
Imamura M; Abrams P; Bain C; Buckley B; Cardozo L; Cody J; Cook J; Eustice S; Glazener C; Grant A; Hay-Smith J; Hislop J; Jenkinson D; Kilonzo M; Nabi G; N'Dow J; Pickard R; Ternent L; Wallace S; Wardle J; Zhu S; Vale L
Health Technol Assess; 2010 Aug; 14(40):1-188, iii-iv. PubMed ID: 20738930
[TBL] [Abstract][Full Text] [Related]
3. Protocol for Physiotherapy Or TVT Randomised Efficacy Trial (PORTRET): a multicentre randomised controlled trial to assess the cost-effectiveness of the tension free vaginal tape versus pelvic floor muscle training in women with symptomatic moderate to severe stress urinary incontinence.
Labrie J; van der Graaf Y; Buskens E; Tiersma SE; van der Vaart HC
BMC Womens Health; 2009 Sep; 9():24. PubMed ID: 19723313
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of stress urinary incontinence-trans-obturator tape compared with tension-free vaginal tape-5-year follow up: an economic evaluation.
Lier D; Robert M; Tang S; Ross S
BJOG; 2017 Aug; 124(9):1431-1439. PubMed ID: 27506185
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of tension-free vaginal tape vs burch colposuspension for female stress urinary incontinence in the USA.
Laudano MA; Seklehner S; Chughtai B; Lee U; Tyagi R; Kavaler E; Te AE; Kaplan SA; Lee RK
BJU Int; 2013 Jul; 112(2):E151-8. PubMed ID: 23773373
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study.
Mihaylova B; Pitman R; Tincello D; van der Vaart H; Tunn R; Timlin L; Quail D; Johns A; Sculpher M
Value Health; 2010 Aug; 13(5):565-72. PubMed ID: 20456715
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine.
Vella M; Duckett J; Basu M
Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):961-4. PubMed ID: 18231697
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of duloxetine in chronic low back pain: a US private payer perspective.
Wielage RC; Bansal M; Andrews JS; Wohlreich MM; Klein RW; Happich M
Value Health; 2013; 16(2):334-44. PubMed ID: 23538186
[TBL] [Abstract][Full Text] [Related]
9. Is Burch colposuspension ever cost-effective compared with tension-free vaginal tape for stress incontinence?
Wu JM; Visco AG; Weidner AC; Myers ER
Am J Obstet Gynecol; 2007 Jul; 197(1):62.e1-5. PubMed ID: 17618760
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States.
Beard SM; Roskell N; Le TK; Zhao Y; Coleman A; Ang D; Lawson K
J Med Econ; 2011; 14(4):463-76. PubMed ID: 21651426
[TBL] [Abstract][Full Text] [Related]
11. Trans-obturator tape compared with tension-free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis.
Lier D; Ross S; Tang S; Robert M; Jacobs P;
BJOG; 2011 Apr; 118(5):550-6. PubMed ID: 21291510
[TBL] [Abstract][Full Text] [Related]
12. Comparison of an adjustable anchored single-incision mini-sling, Ajust(®) , with a standard mid-urethral sling, TVT-O(TM) : a health economic evaluation.
Boyers D; Kilonzo M; Mostafa A; Abdel-Fattah M
BJU Int; 2013 Dec; 112(8):1169-77. PubMed ID: 24053310
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence.
Cody J; Wyness L; Wallace S; Glazener C; Kilonzo M; Stearns S; McCormack K; Vale L; Grant A
Health Technol Assess; 2003; 7(21):iii, 1-189. PubMed ID: 13678548
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.
Brunenberg DE; Joore MA; Veraart CP; Berghmans BC; van der Vaart CH; Severens JL
Clin Ther; 2006 Apr; 28(4):604-18. PubMed ID: 16750472
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of tension-free vaginal tape for the surgical management of female stress incontinence.
Kilonzo M; Vale L; Stearns SC; Grant A; Cody J; Glazener CM; Wallace S; McCormack K
Int J Technol Assess Health Care; 2004; 20(4):455-63. PubMed ID: 15609795
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine treatment for women awaiting continence surgery.
Duckett JR; Aggarwal I; Patil A
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Nov; 17(6):563-5. PubMed ID: 16416257
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of the surgical treatment of female urinary incontinence using slings and meshes.
Montesino-Semper MF; Jimenez-Calvo JM; Cabases JM; Sanchez-Iriso E; Hualde-Alfaro A; García-García D
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):180-6. PubMed ID: 24035322
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
Nordström G; Despiegel N; Marteau F; Danchenko N; Maman K
J Med Econ; 2010; 13(3):516-26. PubMed ID: 20698748
[TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence.
Seklehner S; Laudano MA; Te AE; Kaplan SA; Chughtai B; Lee RK
Neurourol Urodyn; 2014 Nov; 33(8):1186-92. PubMed ID: 23946119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
